微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4.12% | 5.37% | -71.8% | 8/131 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 14.61% | 7.58% | 19.66% | 9/131 | 3.1% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 12.21% | 6.64% | 48% | 14/131 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 8.25% | 6.73% | 111% | 9/131 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 3.91% | 28.2% | -71.21% | 15/131 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 13.58% | 38.71% | 18.6% | 18/131 | 5.12% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 11.45% | 53.07% | 48.12% | 16/131 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 7.73% | 92.77% | 153.44% | 20/131 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 3.05% | 111.81% | -68.85% | 42/131 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 9.79% | -2.3% | 30.88% | 66/131 | 13.36% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 7.48% | -18.43% | 86.53% | 68/131 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.01% | -20.59% | 178.47% | 77/131 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.44% | -42.63% | -85.63% | 75/131 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 10.02% | 18.72% | 9.27% | 81/131 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 9.17% | 10.88% | 81.58% | 65/131 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 5.05% | 20.53% | 101.2% | 80/131 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 2.51% | 32.11% | -70.26% | 60/131 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 8.44% | -57.48% | 2.06% | 95/131 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 8.27% | -61.87% | 97.37% | 60/131 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.19% | -81.55% | 120.53% | 75/131 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 1.9% | 2% | -90.43% | 43/131 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 19.85% | -39.65% | -8.48% | 40/131 | 14.38% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 21.69% | 2% | -4.49% | 9/131 | 10.49% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 22.71% | 34.78% | -30.95% | 2/131 | 6.73% | 心脉医疗 | 31.04% | 行业排名> |
| 2018-12-31 | 32.89% | 25.2% | 25.2% | 10/131 | 12.98% | 新华医疗 | 13.55% | 行业排名> |
| 2017-12-31 | 26.27% | 37.83% | 55.91% | 19/131 | 13.82% | 安旭生物 | 48.71% | 行业排名> |
| 2017-06-30 | 16.85% | 2% | -11.59% | 5/131 | 5.9% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2016-12-31 | 19.06% | 77.63% | 77.63% | 26/131 | 16.21% | 明德生物 | 14.54% | 行业排名> |
| 2015-12-31 | 10.73% | 6.45% | 6.45% | 41/131 | 15.95% | 迈瑞医疗 | 11% | 行业排名> |